Global drugmaker GlaxoSmithKline Pharmaceuticals (GSK) has posted a consolidated net profit of Rs 560.6 crore for the year ended 2010, 10.37 per cent higher compared with the Rs 507.9-crore net profit in the year-ago period. Net sales of the company stood at Rs 2151.05 crore, 12.75 per cent higher than Rs 1907.8 crore a year ago.
GSK Pharma’s sales were supported by all its business units, mass markets, mass speciality and specialities, including dermatological, oncology, critical care and vaccines. The vaccine business recorded a growth of 24 per cent during the year, said Mehernosh Kapadia, executive director.
